
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15990151
[patent_doc_number] => 20200170946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => NANOPARTICLE-LIPID COMPOSITE CARRIERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/615260
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615260 | Nanoparticle-lipid composite carriers and uses thereof | May 23, 2018 | Issued |
Array
(
[id] => 17602927
[patent_doc_number] => 11331396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility
[patent_app_type] => utility
[patent_app_number] => 16/615504
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 10020
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615504 | Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility | May 23, 2018 | Issued |
Array
(
[id] => 16570709
[patent_doc_number] => 20210009715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => NOVEL PSMA-BINDING AGENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/616744
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616744
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616744 | PSMA-binding agents and uses thereof | May 23, 2018 | Issued |
Array
(
[id] => 17193124
[patent_doc_number] => 11161865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Radiolabeled and fluorescent PARP inhibitors for imaging and radiotherapy
[patent_app_type] => utility
[patent_app_number] => 16/616049
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10229
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616049
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616049 | Radiolabeled and fluorescent PARP inhibitors for imaging and radiotherapy | May 23, 2018 | Issued |
Array
(
[id] => 16009391
[patent_doc_number] => 20200179538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => FUNCTIONALIZED NANOPARTICLES AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/614975
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614975 | Functionalized nanoparticles and methods of making and using same | May 20, 2018 | Issued |
Array
(
[id] => 17435896
[patent_doc_number] => 11261208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Compounds for use as iron(III) MRI contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/615024
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 30
[patent_no_of_words] => 15709
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 397
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615024 | Compounds for use as iron(III) MRI contrast agents | May 20, 2018 | Issued |
Array
(
[id] => 18084398
[patent_doc_number] => 11534505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Triaryl methane composition, dye composition for ocular membrane dyeing
[patent_app_type] => utility
[patent_app_number] => 15/984311
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8750
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984311 | Triaryl methane composition, dye composition for ocular membrane dyeing | May 17, 2018 | Issued |
Array
(
[id] => 16087113
[patent_doc_number] => 20200197543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => TUMOR-TARGETING, CLEARABLE HUMAN PROTEIN-BASED MRI NANOPROBES, AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/608837
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608837 | Tumor-targeting, clearable human protein-based MRI nanoprobes, and compositions and methods thereof | May 16, 2018 | Issued |
Array
(
[id] => 18012162
[patent_doc_number] => 11504436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Biogenic hemin-based MRI contrast agents, and compositions and methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/608838
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 5522
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608838
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608838 | Biogenic hemin-based MRI contrast agents, and compositions and methods thereof | May 16, 2018 | Issued |
Array
(
[id] => 14881655
[patent_doc_number] => 10420848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Methods for treating and diagnosing blinding eye diseases
[patent_app_type] => utility
[patent_app_number] => 15/978782
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 40
[patent_no_of_words] => 30773
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978782 | Methods for treating and diagnosing blinding eye diseases | May 13, 2018 | Issued |
Array
(
[id] => 13551679
[patent_doc_number] => 20180327387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => Cyanine Compounds
[patent_app_type] => utility
[patent_app_number] => 15/976491
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 385
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/976491 | Cyanine compounds | May 9, 2018 | Issued |
Array
(
[id] => 15901225
[patent_doc_number] => 20200150131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => DIAGNOSTIC ADVANCED GLYCATION END-PRODUCT ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 16/610473
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610473
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610473 | DIAGNOSTIC ADVANCED GLYCATION END-PRODUCT ANTIBODIES | May 2, 2018 | Abandoned |
Array
(
[id] => 17974410
[patent_doc_number] => 11491247
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Methods and reagents for tumor targeting with greater efficacy and less toxicity
[patent_app_type] => utility
[patent_app_number] => 16/610816
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10052
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/610816 | Methods and reagents for tumor targeting with greater efficacy and less toxicity | May 1, 2018 | Issued |
Array
(
[id] => 17556009
[patent_doc_number] => 11312685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Targeting nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/607554
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 16193
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 467
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607554 | Targeting nanoparticles | Apr 26, 2018 | Issued |
Array
(
[id] => 15524937
[patent_doc_number] => 20200054774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => BIODEGRADABLE MICROSPHERES INCORPORATING RADIONUCLIDES
[patent_app_type] => utility
[patent_app_number] => 16/608976
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608976
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608976 | BIODEGRADABLE MICROSPHERES INCORPORATING RADIONUCLIDES | Apr 25, 2018 | Abandoned |
Array
(
[id] => 15512521
[patent_doc_number] => 10562835
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-02-18
[patent_title] => Method for producing thorium-226
[patent_app_type] => utility
[patent_app_number] => 15/954924
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 5732
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954924
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/954924 | Method for producing thorium-226 | Apr 16, 2018 | Issued |
Array
(
[id] => 16806180
[patent_doc_number] => 20210128733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => BIOORTHOGONAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/603471
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603471 | Bioorthogonal compositions | Apr 5, 2018 | Issued |
Array
(
[id] => 17496543
[patent_doc_number] => 11285227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies
[patent_app_type] => utility
[patent_app_number] => 16/500380
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 17
[patent_no_of_words] => 37646
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500380 | Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies | Apr 4, 2018 | Issued |
Array
(
[id] => 13475803
[patent_doc_number] => 20180289444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => MULTI-MODE IMAGING MARKERS
[patent_app_type] => utility
[patent_app_number] => 15/946479
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946479
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946479 | Multi-mode imaging markers | Apr 4, 2018 | Issued |
Array
(
[id] => 13458001
[patent_doc_number] => 20180280543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => Compounds and Method for Imaging Cancer
[patent_app_type] => utility
[patent_app_number] => 15/944735
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944735 | Compounds and method for imaging cancer | Apr 2, 2018 | Issued |